Minovia Therapeutics to Showcase Innovative Therapies at J.P. Morgan Health Care Conference

Minovia Therapeutics, a clinical-stage global biotechnology company, is thrilled to announce its attendance at the upcoming Biotech Showcase in San Francisco, CA on Tuesday, January 10, 2023. Hosted at the luxurious Hilton San Francisco Union Square Hotel, the showcase is an excellent opportunity for Minovia to network with top industry professionals and share its innovative developments in the biotechnology field.

Biotech Showcase is a must-attend event for investors and biopharma executives alike! Join us at Franciscan C on the Ballroom Level at 9:45 AM PST to get unique insights from some of the top minds in the industry. Don’t miss out on this opportunity to learn from the best and expand your knowledge.

Interested parties can register to attend the event here:

CEO Natalie Yivgi-Ohana and CBO Shai Melcer of our company will be in San Francisco from January 8-12, 2023, to attend the 41st Annual J.P. Morgan Health Care Conference and meet with investors. During this time, they will be available to answer any questions and discuss our company’s progress and future goals. Don’t miss this chance to learn more about what our team is doing and how we’re making a difference in the healthcare industry!

About Minovia

Minovia Therapeutics is a pioneering biotechnology company that is revolutionizing the way diseases caused by mitochondrial dysfunction are treated. Their Mitochondrial Augmentation Technology (MAT) platform utilizes autologous stem cells enriched with healthy, functional mitochondria to restore mitochondrial function. This cutting-edge approach has the potential to greatly extend and enhance human lives. Minovia is currently conducting clinical trials to assess the efficacy of MAT in addressing primary mitochondrial diseases, such as Pearson Syndrome, as well as hematological disorders with mitochondrial dysfunction.

Findings on safety and efficacy of MAT, both pre-clinical and clinical, may be found in these publications:

Minovia, the innovative biotechnology company founded by pioneering researchers in mitochondrial biology, stands at the forefront of revolutionary medical breakthroughs. Boasting a team of world-class scientists, their headquarters in Haifa, Israel and operations in Massachusetts, Minovia is committed to advancing the field of mitochondrial biology and making a lasting impact on the healthcare industry.

Leave a Comment